This inventor holds 2 USPTO granted patents. Top assignee: British Technology Group USA. Active years: 1995-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-1997
Title: David E Harwood: Innovator in Anticoccidial Vaccines
Introduction
David E Harwood is a notable inventor based in Fayetteville, AR (US). He has made significant contributions to the field of veterinary medicine, particularly in the development of anticoccidial vaccines. With a total of 2 patents, his work has the potential to impact the health and well-being of livestock.
Latest Patents
Harwood's latest patents include a recombinant anticoccidial vaccine. This innovative vaccine contains a recombinant peptide with novel epitopes. The recombinant peptide features an amino-terminal amino acid sequence that is unique among known Eimeria antigens. Additionally, recombinant vectors encoding the novel peptide antigen have been deposited under ATCC Accession No. 68450 and ATCC Accession No. 68537.
Career Highlights
David E Harwood is associated with British Technology Group USA, where he continues to advance his research and development efforts. His work in creating effective vaccines showcases his commitment to improving animal health.
Collaborations
One of his notable coworkers is Glenda Hamby, who collaborates with him in his research endeavors.
Conclusion
David E Harwood's contributions to the field of veterinary medicine through his innovative vaccines highlight his role as a key inventor. His work not only advances scientific knowledge but also has practical applications in improving livestock health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile